Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-19

Clinical Trial Update: Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating propranolol hydrochloride in combination with sintilimab and platinum-based chemotherapy for advanced non-small cell lung cancer; enrol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platinum-based chemotherapy (platinum-based chemotherapy)
  • Propranolol Hydrochloride (propranolol hydrochloride)
  • Sintilimab (sintilimab)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Non Small Cell Lung Cancer, Propranolol | Phase 1 | Status: RECRUITING